Skip to content

DABIGA MEDICALE

Active
Private limited companyfounded 2005active for 21 yearsRue Abraham Lincoln 21, 4460 Grâce-Hollogne, BelgiumKBO/BCE: BE 0871.099.887
Summary

DABIGA MEDICALE has been active since 2005 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €343,779 and a net result of €21,022. Equity has been growing by about 8.1% per year since 2018. Its solvency ranks better than 64% of 3,032 sector peers (NACE 86, financial year 2025). The computed 12-month bankruptcy probability is below 0.1% (very low).

Overview

Official details

Source: KBO
Status
Active since 10-01-2005 Normal situation
Activity
Specialist medical practice NACE 86220and 1 other
Joint committee
330 Paritair Comité voor de gezondheidsinrichtingen en -diensten · annual accounts 2025
Establishment unit
2.195.228.774 4460 Grâce-Hollogne, since 22-12-2004
Financial year end
31 December
Peppol
Reachable since 06-03-2026

Board and ownership

Board

Financial position

94 Excellent Checked score 2025
Bankruptcy probabilitywithin 12 months
< 0.1%
Annual accounts 2025
Gross margin
€93,447
▼ 33.6%
Turnover
≈ €230,000
estimated
Profit
€21,022
▼ 65.5%
Equity
€343,779
▲ 6.5%
Total assets
€465,539
▲ 3.5%
Employees on 31-12-2025
1
=
Score breakdownlowers riskSector: Human health activities (NACE 86)Liquidity: current ratio 3.54, cash €175,363Equity €343,779 (73.8% of total assets)Figures for financial year 2025 (filed on 03-07-2026)Show the evidence

Checked score

Score 2025
94 / 100
Excellent
Probability in this band: under 0.55%
Financially stronger than 50% of micro companies in human health (NACE 86)
Financial strength · tick: 2024
Strong
Solvency 99+2
equity 73.8% of total assets
Liquidity 87-2
short-term debt 26.2% · cash 37.7%
Profitability 74-12
return on assets 4.5%
Bankruptcy probability within 12 months
< 0.1% Very low
0%0.5%1.5%4%10%≥ 25%

Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median < 0.1% (24,160 companies, NACE 86, micro)
Last 24 months 12-2024: < 0.1% 01-2025: < 0.1%● unchanged vs 12-2024 02-2025: < 0.1%● unchanged vs 01-2025 03-2025: < 0.1%● unchanged vs 02-2025 04-2025: < 0.1%● unchanged vs 03-2025 05-2025: < 0.1%● unchanged vs 04-2025 06-2025: < 0.1%● unchanged vs 05-2025 07-2025: < 0.1%● unchanged vs 06-2025highest value 08-2025: < 0.1%● unchanged vs 07-2025lowest value 09-2025: < 0.1%● unchanged vs 08-2025lowest value 10-2025: < 0.1%● unchanged vs 09-2025lowest value 11-2025: < 0.1%● unchanged vs 10-2025lowest value 12-2025: < 0.1%● unchanged vs 11-2025lowest value 01-2026: < 0.1%● unchanged vs 12-2025lowest value 02-2026: < 0.1%● unchanged vs 01-2026 03-2026: < 0.1%● unchanged vs 02-2026 04-2026: < 0.1%● unchanged vs 03-2026 05-2026: < 0.1%● unchanged vs 04-2026 06-2026: < 0.1%● unchanged vs 05-2026 07-2026: < 0.1%● unchanged vs 06-2026 08-2026: < 0.1%● unchanged vs 07-2026 09-2026: < 0.1%● unchanged vs 08-2026 10-2026: < 0.1%● unchanged vs 09-2026 11-2026: < 0.1%● unchanged vs 10-2026
Credit of up to €30,000 on 30-day terms is acceptable
Liquidity is ample, with a current ratio of 3.54 (3.17 in 2024), above the usual 1.5. Short-term debt is 26.2% and cash 37.7% of total assets. 26.2% of the assets are financed with debt and provisions.
Calculation

The band follows from the bankruptcy probability. 10 more points roughly halve it.

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 86, micro). It does better than 62% of them on solvency, 70% on liquidity, 18% on profitability and 48% on growth.

The bankruptcy probability was computed on 02-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Five signals.
lowers riskneutral
lowers risk · Sector: Human health activities (NACE 86)
KBO
lowers risk · Liquidity: current ratio 3.54, cash €175,363
NBB · annual accounts
lowers risk · Equity €343,779 (73.8% of total assets)
NBB · annual accounts
lowers risk · Figures for financial year 2025 (filed on 03-07-2026)
NBB · annual accounts
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 03-07-2026, 28 days ahead of the deadline.
NBB · 10 filings
Deviation from the deadline
2025
28 days early
2024
on the day
2023
on the day
2022
1 day early
2021
48 days early
2020
43 days early
2019
58 days early
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

The company filed its last 7 accounts on average 25 days before the deadline. In the sector (NACE 86), the median for financial year 2024 was 7 days before the deadline, and 36% of those companies filed late.

Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 30 July (4 of the last 5 accounts filed within 30 days either side of that date).
Companies Code · seven months
Where today falls in the filing period
02-11-2026 today31-12-2026 year end31-07-2027 deadline
neutral · No strike-offs in the KBO publications
That holds for every publication since 2021.
KBO publications

Key points

  • Positive: Filed on time since financial year 2018accounts within the deadline every year 8 years View
  • Positive: 8 profitable years in a rowprofit 2025: €21,022 8 years View

Recent changes

  1. · Gazette deed Resignation: BIGATTINI Dario (manager)Reappointment: BIGATTINI Dario (director)
  2. · Gazette deed Incorporation
All 15 events

Comparable companies

These companies have the same main activity as DABIGA MEDICALE: specialist medical practice (NACE 86220). They are comparable in size and age: total assets between €412,000 and €672,000, founded between 1998 and 2009.

CompanyTotal assetsGross margin
DABIGA MEDICALE Grâce-Hollogne€465,539€93,447
DOKTER G. GEUENS Nazareth-De Pinte€412,070€111,507
DOKTER MARTIEN VANDENBERGHE, PNEUMOLOOG Pepingen€516,984€117,581
Clinique du Mont Saint Martin Liège€671,826€80,552
NSETHA Elsene€458,137€125,088
DR. GEERT VALGAEREN Schoten€495,467€128,838
DOKTER WALTER PENDERS Lebbeke€659,165€89,580
Full comparison

Key facts about DABIGA MEDICALE

What is the company number of DABIGA MEDICALE?
The company number of DABIGA MEDICALE is 0871.099.887. The VAT number is the same number with BE in front: BE 0871.099.887.
Where is DABIGA MEDICALE based?
The registered office is at Rue Abraham Lincoln 21, 4460 Grâce-Hollogne.Company details
What does DABIGA MEDICALE do?
According to the KBO register, the main activity is specialist medical practice (NACE 86220).
What is the legal form of DABIGA MEDICALE?
The legal form of DABIGA MEDICALE is Private limited company (BV).
When was DABIGA MEDICALE founded?
DABIGA MEDICALE was founded on 10-01-2005.
Is DABIGA MEDICALE still active?
Yes, DABIGA MEDICALE is an active enterprise in the KBO register.
How many employees does DABIGA MEDICALE have?
DABIGA MEDICALE had an average of 0.6 full-time equivalents in financial year 2025, according to the filed annual accounts.Financials
Which joint committee does DABIGA MEDICALE fall under?
In its 2025 annual accounts, DABIGA MEDICALE states joint committee 330 (Paritair Comité voor de gezondheidsinrichtingen en -diensten).
What is the turnover of DABIGA MEDICALE?
The turnover in financial year 2025 is ≈ €230,000. This figure is estimated from the gross margin of €93,447 and 47 comparable companies (NACE 862). It probably lies between €170,000 and €350,000.
Is DABIGA MEDICALE profitable?
In financial year 2025, DABIGA MEDICALE made a profit of €21,022.
Where can I find the annual accounts of DABIGA MEDICALE?
DABIGA MEDICALE filed 21 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of DABIGA MEDICALE due?
DABIGA MEDICALE must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.